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Summary
With the advancement in drug development, multiple treatments are available for a
single disease. Patients can often benefit from taking multiple treatments simulta-
neously. For example, patients in Clinical Practice Research Datalink (CPRD) with
chronic diseases such as type 2 diabetes can receive multiple treatments simultane-
ously. Therefore, it is important to estimate what combination therapy from which
patients can benefit themost. However, to recommend the best treatment combination
is not a single-label but a multi-label classification problem. In this paper, we pro-
pose a novel outcome weighted deep learning algorithm to estimate individualized
optimal combination therapy. The fisher consistency of the proposed loss function
under certain conditions is also provided. In addition, we extend our method to a
family of loss functions, which allows adaptive changes based on treatment interac-
tions. We demonstrate the performance of our methods through simulations and real
data analysis.
KEYWORDS:
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1 INTRODUCTION
In recent years, precision medicine has become an important topic in both industry and academia. It aims to find a mechanism of
treatment assignment such that the patient can benefit the most. A lot of researchers have conducted vast investigations through
different approaches. For example, the framework of outcome weighted learning is proposed to identify the individualized
treatment rule (ITR) in [1]. Alternatively, Zhang et al. [2] [3] propose another general framework of estimating optimal treatment
regimes with robustness from the perspective of classification. Fu, Zhou and Faries [4] develop a comprehensive binary search
approach, which is easy to interpret and apply in clinical study. Chen [5] further extends the outcome weighted learning to
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other models and loss functions. However, these methods only focus on binary treatment recommendation. To handle multiple
treatments, Zhang et al. [6] develop a multi-category outcome weighted learning approach using angle based classifiers. Their
model essentially assumes that each patient takes one out of multiple treatments. However, in reality, patients can benefit from
taking multiple treatments simultaneously. Therefore, it is of great interest to develop methods for precision medicine in the
context of combination therapies.
The adoption of combination therapies in medication is inevitable, especially in chronic diseases. For example, patients
with type 2 diabetes often receive multiple medications, because single treatment may be insufficient to effectively control the
blood glucose level. Hence, medications exerting their effects through different mechanisms are needed. For instance, DPP4
increases incretin level, which inhibits glucagon release. Sulfonylurea increases insulin release from 훽-cell in pancreas. DDP4
and Sulfonylurea function through different biological pathways, while serving the same purpose of reducing blood glucose.
Thus, we can expect better control in blood glucose when taking both medications. In addition, diabetes may also cause other
complications which require additional medications. Due to these two reasons, patients with type 2 diabetes are very likely to
receive a combination of multiple treatments, and so is the case in other chronic diseases such as cancer, and chronic heart failure
(CHF).
However, existing algorithms may not be adequate to precision medicine with combination therapies. Algorithms for multi-
class classification are not scalable with the increasing number of treatments, that is, if we have 퐾 treatments, there are 2퐾
possible combinations,which implies at least 2퐾−1 classifiers. This is the consequence of treating each combination individually
without considering the underlying structures among those treatments. For example, DDP4 and Sulfonylurea can reduce A1c by
0.5% and 1.0%, respectively. If the treatment effects of DDP4 and Sulfonylurea are additive, combining these two medications
together can reduce A1c by 1.5% . If small interaction exists, the reduction is expected to lie between 1.0% and 2.0%. Our
proposed method is able to leverage this information to improve the learning efficiency, which will be elaborated in Section 6
and 7.
Different from the traditional supervised learning, the estimand is the optimal treatment assignment which is not directly
observed from the patients. For example, in a classification problem, the correct label 푌 is observed for each observed covariates
푋. Similarly, in a regression problem, an outcome푌 is also observed for each observed covariates푋. In our treatment assignment
problem, information about optimal treatment assignment rule is only available indirectly through the outcome due to the fact
that only one potential outcome can be observed. In this paper, we extend deep learning algorithms, and propose an outcome
weighted loss function to estimate optimal treatment assignment rule for combination therapies.
Our paper is organized in the following manner. Section 2 provides a brief review to outcome weighted learning and multi-
label classification problem. It explains the necessity of using multi-label classification rather than multi-class classification,
and also addresses some requirements that a good method needs to achieve. Section 3 incorporates multi-label classification
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with outcome weighted learning, and illustrates basic properties of our proposed method. Section 5 further provides theoretical
justifications on the fisher consistency under general cases and a special case with additive treatment effect and small interactions.
Section 6 and 7 show the advantages of our method through simulations and real data analysis. In section 8, our method is further
extended to a family of loss function which can be adaptive to the treatment interactions. We also discuss other possible future
extensions in section 8.
2 REVIEW
In this section, we will review some literature related to precision medicine and multi-label classification. In the meantime, the
keys to solve this problem are identified.
Precision medicine has been a hot topic for years. On the one hand, outcome weighted learning proposed in [1] is one of the
most popular method. Outcome weighted learning finds the optimal decision rule that maximizes the conditional expectation of
the outcome given the decision rule. Let푋 be the covariates, function퐷(⋅) be the decision rule, which is a mapping from space
of covariates  to the space of treatment . The conditional expectation of the outcome 푅 ∈ ℝ given treatment assignment
퐷(푋) can be written as:
퐸퐷(푅) = 퐸
[
푅
휋퐴
퐼{퐴 = 퐷(푋)}
]
, (1)
where 휋푎 = Pr(퐴 = 푎|푋), where퐴 is the random variable of treatment assignment and 푎 ∈  is a treatment. In this framework,
searching for the best treatment assignment 퐷 to maximize 퐸퐷(푅) is converted into a classification problem. Similar to the
multi-class classification problem, the outcome weighted learning framework (1) can also be applied to multiple treatments
problems using angel based learning [6]. On the other hand, researchers also propose another general framework in [2, 3], which
estimates the contrast function of the treatment effect directly. The proposed methods in [2] and [3] also enjoy the advantage
of double robustness which allows for misspecification on either potential outcome model or propensity score model. Chen [5]
further extends the ideas in [1] and [3] to more general loss functions.
However, different from traditional multi-class classification problem where each patient is assigned to one of the treatments,
multi-label classification problem allows patients to be assigned to a combination of multiple treatments. A naive implementa-
tion called Label Powerset (LP) transforms a multi-label classification problem with퐾 treatments (or classes) into a multi-class
classification problem with 2퐾 classes, therefore, the dimension increases exponentially with the number of treatment 퐾 . To
avoid the curse of dimensionality and to increase efficiency, two strategies are often adopted. The first strategy is Binary Rel-
evance (BR) [7]. It transforms the original problem to a 퐾 independent binary classification problem. For example, suppose
 = {푎1, 푎2,⋯ , 푎퐾}, BR type of methods build퐾 classifiers to individually and independently decide whether 푎푘, 푘 = 1,⋯ , 퐾 ,
should be adopted. In this case, assumed linear classification rule with 푝-dimensional covariates, at least 퐾푝 coefficients need
4 Liang, Ye and Fu
to be estimated, which is much smaller than that of LP. However, it is broadly criticized by its independent assumption on treat-
ments (or classes). Therefore, ranking by pairwise comparison [8] is proposed. However, this method only provides a ranking
of the treatments. It does not provide any ‘zero’ point to separate treatments which are beneficial from those are harmful.
Besides those attempts to convert the multi-label classification problem into other problems, an alternative is adopting an
appropriate loss. One of the commonly adopted loss function is Hamming loss. Let 퐴 = (퐴1,⋯ , 퐴퐾) ∈  represents a vector
of length 퐾 , where  = {−1, 1}퐾 . If the 푘th treatment is adopted, then 퐴푘 = 1; If not, then 퐴푘 = −1. Accordingly, decision
rule 퐷(푋) = (퐷1(푋),⋯ , 퐷퐾(푋)) ∈ {−1, 1}
퐾 . Hamming loss of a decision rule 퐷(⋅) given the sample (푋,퐴) is defined as
1
퐾
퐾∑
푘=1
퐼{퐴푘 ≠ 퐷푘(푋)}. (2)
And it can be interpreted as the proportion of the misclassified labels. Say there are only 3 treatments (labels), the relationship
between Hamming loss and 0-1 loss is shown in Figure 1 .
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FIGURE 1 The left is the 0-1 loss, the right is the Hamming loss. Hamming loss is a step function and bounded by 0-1 loss.
Another interesting topic is the shared subspace. The idea proposed by [9] assumes that all the decision rules are directly
depend on the same subspace of covariates. Similar to central mean space estimation in sufficient dimension reduction [10],
shared subspace essentially assumes that for certain 퐵, there exist 퐷̄푘’s such that 퐷푘(푋) = 퐷̄푘(퐵
⊤푋), for all 푘 ∈ 1,⋯ , 퐾 .
Through shared subspace, we can always borrow some efficiency from other treatments, and thus facilitate the estimation of
unknown non-linear relationship.
In addition, scalability of the algorithm is also important because heavy computation complexity can undermine its practical
application. Multi-label classification enables the scalable computation with respect to the number of treatments. The algorithm
still needs to be scalable with the increasing sample size.
From this review of the literature, it’s clear that the method we are looking for should fully address the following issues:
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1. Applicability to precision medicine.
2. Appropriate loss with the framework of multi-label classification.
3. Shared subspace.
4. Scalable computation with both number of treatments and sample size.
3 METHOD
In this section, a loss function is proposed within outcome weighted learning framework, which takes advantage of multi-label
classification. Our classifier based on neural networks (NN) is introduced and combined with the proposed loss function. NN as
a classifier naturally satisfies the requirement of shared subspace. And its algorithm is also scalable with the sample size.
3.1 Outcome weighted learning with multi-label classification
Let 푋푖 ∈  be the column vector of 푝-dimensional covariates for 푖th patient among total 푛 patients, 퐴푖 = (퐴푖1,⋯ , 퐴푖퐾 ) ∈
{−1, 1}퐾 is the treatment assignment of the 푖th patient, and 푅푖 ∈ ℝ is the observed outcome of the 푖th patient. Again, decision
rule is denoted as
퐷(푋) = (퐷1(푋),⋯ , 퐷퐾(푋)) ∈ {−1, 1}
퐾 .
Considering the following loss function for a given decision rule 퐷(푋),
퐿(퐷) =
1
푛
푛∑
푖=1
푅푖
휋퐴푖
1
퐾
퐾∑
푘=1
퐼{퐴푖푘 ≠ 퐷푘(푋푖)}, (3)
where 휋퐴푖 may be known in clinical trial or estimated in observational study. When the problem is a multi-class classification
problem, the loss above is exactly equal to the outcome weighted 0-1 loss proposed in [1]. When the problem is a multi-label
classification problem, the proposed loss (3) is upper bounded by the outcome weighted 0-1 loss in outcome weighted learning.
In addition, if
푅푖
휋퐴푖
is a constant, it reduces to Hamming loss. The loss function proposed in (3) combines the loss in outcome
weighted learning and Hamming loss. Thus, we call it outcome weighted Hamming loss.
One of the difficulty in optimizing the proposed loss (3) is the non-smoothness and non-convexity of indicator functions.
Hinge loss [11] or logistic loss can be adopted as surrogate losses for indicator functions. The fisher consistency of proposed loss
in (3) and its surrogate loss are provided in the following sections. As proved in Section 5, our proposed loss is fisher consistent
under small amount of interactions.
Another difficulty of the proposed method comes from the estimation of 휋퐴푖 . We provide two solutions to this issue when
퐾 is large. First solution assumes that the treatment assignment 퐴 is independent with the covariates 푋. In this case, 푃 (퐴 =
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푎|푋) = 푃 (퐴 = 푎) can be estimated by the proportion of the patients with 퐴 = 푎 in the sample. Second solution assumes that
each treatment assignment 퐴푘 are independent with each other given covariates 푋. In this case, 푃 (퐴 = 푎|푋) = ∏퐾푘=1 푃 (퐴푘 =
푎푘|푋) and each 푃 (퐴푘 = 푎푘|푋)’s can be estimated by logistic regression because 퐴푘 are binary. When 퐾 is small, multinomial
regression can also be used to estimate 푃 (퐴 = 푎|푋) directly. For simplicity, the first solution is adopted in Section 6 and Section
7.
3.2 Decision rule with deep learning
In the previous section, outcomeweighted Hamming loss is defined. Admittedly any suitable classifier can fit into our framework,
the classifier adopted in this paper is the Neural Network (NN) for its advantages in shared subspace and scalable computation.
To simply illustrate our idea, we start from a 3-layer NN. The first layer on the bottom is the input layer where 푋푖 =
(푋푖1,⋯ , 푋푖푝)
⊤ is the input vector of covariates. The layer in the middle is the hidden layer with 푑 hidden variables. The top layer
consists of퐾 output variables. An example of the graph structure of this NN is presented in Figure 3 . In this toy example, only
3 treatments are considered, say treatment 퐸, treatment 퐹 , and treatment 퐺. Thus, = {−1, 1}3. For example, (1, 1,−1) repre-
sents 퐸퐹 which is the combination of treatment퐸 represented by (1,−1,−1), and 퐹 represented by (−1, 1,−1). The 푘th output
in the top layer is 퐷̃푘(푋푖) given 푋푖 in the input layer. The sign of 퐷̃푘(푋푖) indicates the treatment assignment of 푘th treatment,
which is퐷푘(푋푖). As shown in Figure 3 , the adjacent layers are fully connected and no variables in the same layer are connected.
Given the graphic structure described above, many NNs can fit into this framework. For example, Deep Belief Nets (DBN)
proposed in [12], which consists of stacks of Restricted Boltzmann Machines (RBMs) and a classifier based on the very top
hidden layer. Another common choice is Deep Neural Network (DNN), which is a large NN without probabilistic modeling.
DNN can be obtained by firstly training a DBN and then fine-tuning by back-propagation. This approach of building DNN often
times can help avoid local minimizers and obtain better generalization error. However, the topologies of DBN and DNN are
slightly different. Although the skeleton for both are the same as shown in Fig 2 , the directions of the connected lines can be
different. In DBN, besides the top two layers, all connections between hidden layer and hidden layer or hidden layer and visible
layer are bi-directional (or undirected), and only connections between top two layers are directed from the hidden layer to the
output. In DNN, all connections are directed from lower layers to higher layers. Directed connections are defined by relationship
similar to (4) and (5), which have no probabilistic framework. Bi-directional (or undirected) connections are defined through
undirected graphical models, such as RBM [13]. Thus, the nodes connected by bi-directional (or undirected) connections are
random variables. The value of the node is either a random sample from the defined conditional distribution or the conditional
expectation given other nodes. For example, if the lower layer on the right in Fig 2 is defined by RBM and denote the input
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layer as 푣, the first hidden layer as ℎ, the joint density function of (푣, ℎ) is defined as
푓(푣,ℎ)(푣, ℎ) =
1
푍(휃)
exp{−퐸(푣, ℎ; 휃)},
where 휃 is unknown parameter,푍(휃) is a normalization constant,퐸(푣, ℎ; 휃) is energy functionwhich has certain forms depending
on the type of the model [13]. If 휃 is known, given an input 푣, the conditional distribution of ℎ given 푣 can be calculated. Either
a random sample from this conditional distribution or conditional expectation of ℎ given 푣 can be used as the input for next
layers. The density function of 푣 is
푓푣(푣) = ∫
1
푍(휃)
exp{−퐸(푣, ℎ; 휃)}푑ℎ.
Then 휃 can be estimated by the maximize likelihood estimation (MLE) given observed data 푣. However, In this paper, we focus
on DNN in both simulations and real data analysis.
DNN is defined in the following fashion. For clarification, we explicitly define those variables and weights of connections
given toy example in Fig 3 . Let the input layer in the very bottom be 푣 = (푣1,⋯ , 푣푝) ∈ ℝ
푝, the hidden layer (consists of 푑
hidden variables) in the middle be ℎ = (ℎ1,⋯ , ℎ푑) ∈ ℝ
푑 , and the output layer on the very top be 퐷̃ = (퐷̃1,⋯ , 퐷̃퐾 ) ∈ ℝ
퐾 . Let
푊1 be the 푝× 푑 matrix representing the weights on connections between input layer and hidden layer. For example, the entry of
푊1 on Row 3 and Column 4 is the weight on connection between 푣3 and ℎ4. Similarly, let푊2 be the 푑 ×퐾 matrix representing
the weights on connections between hidden layer and output layer. For example, the entry of푊2 on Row 3 and Column 2 is the
weight on connection between ℎ3 and 퐷̃2. Now, with these notations, the relationship between these variables can be defined as
the following:
ℎ = 푅푒퐿푈 (푊 ⊤
1
푣 + ℎ0), (4)
퐷̃ = 푊 ⊤
2
ℎ + 퐷̃0, (5)
where 푅푒퐿푈 (⋅) is ReLU function defined as 푅푒퐿푈 (푡) = 푡1{푡 > 0}, for any 푡 ∈ ℝ. 푅푒퐿푈 (푂) with a vector 푂 represents a
vector with ReLU function applied to each entry of푂. ℎ0 is a constant 푑-dimensional vector and 퐷̃0 is a constant퐾-dimensional
vector. Apparently, from the above relationship, 퐷̃ can be written as 퐷̃(푣) = (퐷̃1(푣),⋯ , 퐷̃퐾 (푣)). Having the indicator function
replaced by Hinge loss [11], we can formulate the optimization problem as follows,
minimize휃
1
푛
푛∑
푖=1
푅푖
휋퐴푖
1
퐾
퐾∑
푘=1
[
1 −퐴푖푘퐷̃푘(푋푖)
]
+
, (6)
where 휃 = (푊1, ℎ0,푊2, 퐷̃0) and [⋅]+ represents taking non-negative part. This optimization problem can be solved directly by
back-propagation and SGD. Note that the structure of DNN and the activation function can be modified based on real data. The
final estimated decision rule, 퐷̂, is the sign of 퐷̃ given the minimizer of (6), 휃̂.
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FIGURE 2 The left is the structure of DNN and the right is that of DBN. The solid connections represent a directed edge from
the lower layer to the top layer. The dashed connections represent bi-directional (or undirected) connections.
FIGURE 3 The first layer on the bottom is the input layer where 푋푖 = (푋푖1,⋯ , 푋푖푝)
⊤ is the input. The layer on the top is
hidden layer with 푑 hidden variables. The top layer consists of 퐾 output random variables.
NN is a natural choice in this setting for the following reasons. First, the optimization of NN given the proposed loss in (3)
can be implemented by back-propagation [14] and stochastic gradient descent (SGD) [15], which is scalable in terms of sample
size due to the nature of SGD. Second, the decisions are made based on hidden layers which depend on some shared linear
directions of푋푖 and a pre-specified non-linear activation functions [16]. Thus, the subspace of these퐾 decision rules are shared.
Third, the hidden variables can capture complicated correlations among treatments, which is quite clear in the point of graphical
model that given 푋푖, 퐷̃푘’s are not independent with each other. Based on universal approximation theorem proved in [17],
hidden variables also introduce more flexibility into the model. Without the hidden layers, NN is equivalent to a linear model.
In most applications, the structure of hidden layers such as the number of hidden layers and the number of hidden variables in
each hidden layer is adjustable. More complicated the hidden structure is, more flexible the decision rule can be. Thus, our NN
decision rule with proposed loss function in (3) can fully satisfy our requirements. Another ad hoc view of the hidden layers in
Fig 3 is that those hidden variables may represent certain biological pathways through which certain treatment can affect the
outcome. Thus, the decision rule is reasonable to depend on certain hidden variables.
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3.3 Overfitting
Due to strong representative power of DNN, how to avoid over-fitting has become a big issue. To avoid over-fitting, a commonly
used strategy is regularization through penalization. Mathematically, we can consider to solve the following problem:
minimize휃
1
푛
푛∑
푖=1
푅푖
휋퐴푖
1
퐾
퐾∑
푘=1
[1 −퐴푖푘퐷̃푘(푋푖)]+ + 휆푝(푊1,푊2), (7)
where 휃 = (푊1, ℎ0,푊2, 퐷̃0). 푝(푊1,푊2) is the penalty on푊1 and푊2. For example, 푝(푊1,푊2) = ‖푊1‖2퐹 + ‖푊2‖2퐹 is the ridge
penalty, where ‖ ⋅ ‖퐹 is the Frobenius norm, and 푝(푊1,푊2) = ‖푊1‖1 + ‖푊2‖1 is lasso penalty, where ‖ ⋅ ‖1 represents the sum
of absolute value of all entries. Both ridge penalty and lasso penalty can shrink the weights towards 0, but the advantage of lasso
penalty is that it can produce sparse solutions. Another popular method to prevent over-fitting is the so-called dropout proposed
in [18]. Wager et al. [19] argue that dropout is closely related to adaptive penalization and they also clarify its relationship with
ridge penalty. In general, both regularization and dropout are possible choices to prevent over-fitting.
In both regularization and dropout, how to choose the tuning parameter has been investigated for years[18, 20, 21]. Cross-
validation or training-validation-testing data split can be used to evaluate the prediction error and select tuning parameters with
the best performance.
Other parameters such as number of layers and number of nodes each layer also play an important role in balancing under-
fitting and over-fitting. Of course, cross-validation or training-validation-testing data split can be applied to tune the NN’s
structure, but it is extremely computational intensive and impractical some times. In general, how to design NN’s structure is
still an open problem, but extensive researches have been done in this field. On the one hand, some researchers are working on
using genetic algorithm and reinforcement learning to decide these parameters [22, 23]. On the other hand, sparsity induced
by lasso penalty can partially solve this issue. Suppose that all weights connected to a particular variable are 0, it is equivalent
to excluding this variable in the structure of NN. Additionally, other penalties, for example, in [24], weights connected to a
particular variable can be forced to be 0 and thus the node is excluded in the structure. Thus, in practice, we may suggest a
structure as more complex as possible considering the sample size and employ lasso penalty or other penalties to help select
nodes included in the structure automatically.
4 ALGORITHM
In this section, we introduce the algorithm to solve the proposed optimization problem. A straightforward solution is back-
propagation with stochastic gradient descent (SGD). Back-propagation proposed in [13] is an efficient algorithm to numerically
compute the derivatives with respect to certain weight given a NN. SGD provides an computational effect alternative to gradient
descent. Beyond directly implementing SGD, pre-training can also be used to prevent local minimizers and facilitate convergence
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of the algorithm. One of the pre-training procedure utilizes Restricted Boltzmann Machine (RBM) [13]. In this procedure, we
firstly train stacks of RBM in such fashion that the first RBM is trained on observed covariates and next RBM is trained on
the top of the first one, taking the hidden layer in the first RBM as the visible layer in the next RBM, and so on. Then, for the
two layers on the very top, a multi-label classifier based on outcome weighted Hamming loss is trained. After this pre-training
procedure, the whole network is fine-tuned by back-propagation and SGD.
4.1 Stochastic gradient descent
In this section, we briefly introduce the stochastic gradient descent (SGD) under general empirical risk minimization. Say we
want to minimize the following loss function
min
휃
1
푛
푛∑
푖=1
푙(푌푖, 푋푖; 휃), (8)
where 휃 is the general notation for all parameters of interest, (푋푖, 푌푖), 푖 = 1,⋯ , 푛 is the observed data. In gradient descent, we
have
휃(푚+1) ← 휃(푚) − 푡
1
푛
푛∑
푖=1
∇휃푙(푌푖, 푋푖; 휃), (9)
where 휃(푚) is the value of 휃 at the 푚 step, and 푡 > 0 is a scalar called learning rate (step size). In stochastic gradient descent, we
have
휃(푚+1) ← 휃(푚) − 푡
1| (푚)| ∑
푖∈ (푚)
∇휃푙(푌푖, 푋푖; 휃), (10)
where  (푚) is a random sample from {1,⋯ , 푛} with or without replacement, and | (푚)| is the cardinality of the set  (푚), which
is a pre-specified batch size. It is easy to see that
퐸
[
1| (푚)| ∑
푖∈ (푚)
∇휃푙(푌푖, 푋푖; 휃)
]
=
1
푛
푛∑
푖=1
∇휃푙(푌푖, 푋푖; 휃), (11)
where 퐸 [⋅] is the expectation of random sampling. Because each update only depends on a small size of random sample, it is
scalable with the increase of sample size.
In each update of SGD, gradient is computed on a small batch based on a sub-sample of training dataset. On the one hand,
the stochastic induced by sub-sampling prevents the algorithm from falling into local minimizers. On the other hand, it reduces
the computation complexity dramatically compared with usual gradient descent. In general, SGD converges faster than usual
gradient descent, especially for statistical problems [25]. However, due to the stochastic nature of SGD, the calculated gradient
based on a batch is mostly not zero even at the global minimizer. Thus, the variance of sampling small batches has an impact on
the updates of each iteration. To reduce this variance, SVRG and other techniques [26] are proposed. Another simple strategy is
to gradually increase the size of the batch in gradient calculation and decrease learning rate (step size) exponentially in gradient
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update. The convergence of SGD has been proved in strictly convex problem [25], while generally the convergence of SGD is
still an open problem.
4.2 Implementation
In this section, we introduce some packages to implement SGD. A well known package in Python is called Tensorflow devel-
oped by Google. Tensorflow provides an extremely powerful tool to customize NN (number of layers and number of nodes
each layer) and SGD (batch size and step size). It also includes some well-developed advanced algorithm for SGD and keeps
updating. Compared with Tensorflow, Keras is a high-level NN API which is more user-friendly. It allows researchers to build
a very flexible NN with a few lines of code. The down side is that it may not be easy to customize everything using Keras.
Recently, R initiated an access to Tensorflow, which is more friendly to statistical programmers. An experimental R package to
implement the Keras is also available on GitHub. Readers can get more information on R versions of Tensorflow and Keras on
https://tensorflow.rstudio.com.
5 THEORETICAL RESULT
In this section, the theoretical justification of our proposed loss is provided. In the first part, we prove the fisher consistency
of outcome weighted Hamming loss, which implies that minimizing the proposed loss is equivalent to minimizing the original
outcomeweighted 0-1 loss. In the second part, surrogate loss for outcomeweightedHamming loss is proposed and its consistency
with outcome weighted Hamming loss is also provided, which indicates that minimizing the surrogate loss is also equivalent to
minimizing the outcomeweighted Hamming loss. Combining these two parts of theoretical results provides an overall theoretical
support for our proposed method.
Without loss of generality, we assume that outcome 푅 is non-negative.
5.1 Fisher consistency of Hamming loss
We establish the fisher consistency of outcomeweighted Hamming loss in this section, indicating the equivalence of minimizing
outcomeweightedHamming loss and outcomeweighted 0-1 loss. Let퐷∗(푋) = (퐷∗
1
(푋),⋯ , 퐷∗
퐾
(푋)) ∈ {−1, 1}퐾 be the decision
rule that minimizes outcome weighted 0-1 loss:
(퐷) = 퐸
[
푅
휋퐴
퐼{퐴 ≠ 퐷(푋)}
]
. (12)
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It is easy to see that 퐷∗(푋) = {푎 ∶ max푎퐸[푅|퐴 = 푎,푋]}. Again, outcome weighted Hamming loss is defined as
퐻 (퐷) = 퐸
[
푅
휋퐴
1
퐾
퐾∑
푘=1
퐼{퐴푘 ≠ 퐷푘(푋)}
]
. (13)
Theorem 1 (Fisher consistency of outcome weighted Hamming loss). Suppose
퐷∗
푘
(푋) = sign
{ ∑
{푎∶푎푘=1}
퐸[푅|퐴 = 푎,푋] − ∑
{푎∶푎푘=−1}
퐸[푅|퐴 = 푎,푋]} ,
then any function 푓 such that
퐻 (푓 ) = inf
퐷
{퐻 (퐷)}
satisfies
(푓 ) = inf
퐷
{(퐷)}.
Note that in many cases, condition 퐷∗
푘
(푋) = sign
{∑
{푎∶푎푘=1}
퐸[푅|퐴 = 푎,푋] −∑{푎∶푎푘=−1} 퐸[푅|퐴 = 푎,푋]} holds. For
example, a sufficient condition is when treatment effects are additive and there is no interaction, i.e. 퐸[푅|퐴 = 푎,푋] =∑
{푘∶푎푘=1}
푇푒푘 (푋) + 푚(푋), where 푇푒푘 , 푘 = 1,⋯ , 퐾 , is the treatment effect given only treatment 푘, 푒푘 is a 퐾-dimensional vector
having the 푘th entry equals 1 and all other entries equal −1. Moreover, small interactions are tolerable, as stated in Theorem 2.
Theorem 2 (Fisher consistency in special case). Suppose that
퐸[푅|퐴 = 푎,푋] = ∑
{푘∶푎푘=1}
푇푒푘 (푋) + 푟푎(푋) + 푚(푋),
where 푇푒푘(푋) is the treatment effect of only 푘th treatment being adopted, 푟푎(푋) is the additional interaction, and 푚(푋) is
the main effect. If 2 sup푎 |푟푎(푋)| < inf푘 |푇푒푘(푋)| for all 푋, then any function 푓 such that
퐻 (푓 ) = inf
퐷
{퐻 (퐷)}
satisfies
(푓 ) = inf
퐷
{(퐷)}.
Theorem 2 provides a sufficient condition for fisher consistency of outcome weighted Hamming loss. It essentially provides
a theoretical guarantee of the robustness of our method against small interactions. When the condition is violated, our method
is not necessarily consistent and its performance depends on the magnitude of interactions and amounts of patient affected. In
simulation, we compare the performance our method with other methods under small violation of this condition.
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5.2 Multi-label consistency of surrogate loss
Minimizing the proposed loss (3) is still very hard due to the non-smoothness and non-convexity of indicator functions. There-
fore, it is natural to replace the indicator functions in outcome weighted Hamming loss with some surrogate loss. For example,
a common choice for outcome weighted Hamming loss is
Φ퐻 (퐷̃) = 퐸
[
푅
휋퐴
1
퐾
퐾∑
푘=1
휙(퐴푘퐷̃푘(푋))
]
, (14)
where 휙 is a pre-defined convex function. Still, it is critical that minimizing the surrogate loss is equivalent to minimizing
the original outcome weighted Hamming loss. Unfortunately, not every 휙 satisfies this condition. As shown in the following
theorem, (14) is consistent with outcome weighted Hamming loss if 휙 is one of the following:
1. Exponential: 휙(푥) = 푒−푥;
2. Hinge: 휙(푥) = (1 − 푥)+;
3. Least squares: 휙(푥) = (1 − 푥)2;
4. Logistic Regression: 휙(푥) = ln(1 + 푒−푥).
Formally, we have the following theorem.
Theorem 3 (Multi-label consistency of surrogate loss). Suppose
휙′(0) < 0,
for any function 푓̃ such that
Φ퐻 (푓̃ ) = inf
퐷̃
{Φ퐻 (퐷̃)},
let 푓 = sign(푓̃ ), then 푓 satisfies
퐻 (푓 ) = inf
퐷
{퐻 (퐷)}.
6 SIMULATION
6.1 Simulation with correctly specified model
In this section, we will illustrate the performance of two DNN approaches under outcome weighted Hamming loss in (6) by
comparing with a naive method through simulations. In the following simulation settings, 퐾 = 5, so in total there are 25 = 32
combinations of treatments. The dimension of covariates is set to be 푝 = 30, which is common in clinical trials. As explained
in Section 2, the 퐾 treatment multi-label problem can be decomposed to a multi-class problem with 2퐾 classes. The naive
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method further converts the multi-class problem to a series of two-class classification problem, where for each, it directly learns
a binary classifier with linear decision rule through outcome weighted learning. To form a multi-class classifier with 32 different
classifiers with intercepts, 2퐾 (2퐾 − 1)(푝 + 1)∕2 = 15376 coefficients in 2퐾 (2퐾 − 1)∕2 = 496 different linear decision rules
have to be estimated. The first DNN approach, DNN-simple, is a DNN with only input and output layer. For any monotone
activation function, DNN-simple is equivalent to 퐾 = 5 binary linear classifiers with no shared subspace. In general, the only
difference between DNN-simple and naive method is how to form the classifier for multi-label classification. In DNN-simple,
only 퐾 × 푝 +퐾 = 155 parameters needs to be estimated. The comparison of DNN-simple and naive method essentially shows
the efficiency boosting by adopting our proposed outcome weighted Hamming loss. The other DNN approach, DNN-1hdd, adds
one hidden layer between input layer and output layer as shown on the left in Figure 2 . The hidden layer is fully connected
with the input layer and the output layer.The NN structure allows for more flexibility and hence more parameters. In DNN-1hdd
method, suppose the number of hidden variable is 푛ℎ, the total number of parameters to be estimated is 푝(푛ℎ +1)+ 푛ℎ(퐾 +1) =
푝+푛ℎ(푝+퐾 +1) = 30+36푛ℎ. By comparing DNN-simple and DNN-1hdd, it is easy to tell the loss and gain to accommodate a
more flexible model. In addition, the Bayes rule is also evaluated, simply to quantifies the signal-to-noise ratio in our simulation
settings. The Bayes rule is the treatment assignment which gives the largest conditional expectation of the potential outcomes,
i.e.
퐷B(푋) = argmax
푎
퐸 [푅|퐴 = 푎,푋] . (15)
The Bayes rule is impossible to implement in reality, but in simulations, since we know the data generating procedure, we can
directly evaluate 퐸 [푅|퐴 = 푎,푋].
In the simulation, every patient has the same probability to receive one of the treatment combination, and for each treatment,
the treatment effect is generated from a NN with one hidden layer as shown in the left of Figure 2 . The number of the hidden
variables in the hidden layer is 푛ℎ = 45. Firstly, we define the treatment effect of the 푘th treatment for 푖th patient 푇푘,푖. Let
ℎ = 푅푒퐿푈 (푊 ⊤
1
푋푖), (16)
푇푘,푖 = sign
(
푊 ⊤
2,⋅,푘
ℎ
)⎧⎪⎨⎪⎩
0.05 exp
{
푊 ⊤
2,⋅,푘
ℎ
}
1 + exp
{
푊 ⊤
2,⋅,푘
ℎ
} + 2.0⎫⎪⎬⎪⎭ , (17)
where ℎ is the hidden layer which is a 푛ℎ-dimensional vector,푊2,⋅,푘 is the 푘th column of푊2, and sign(⋅) is the function of taking
sign coordinate-wise. All entries in푊1 and푊2 are generated from a standard normal distribution independently. Secondly, the
main effect is defined by the following:
푀푖 = 0.05
exp
{
훾⊤푋푖
}
1 + exp
{
훾⊤푋푖
} − 2.05, (18)
where 훾’s are the coefficients for main effect, whose entries are also generated from a standard normal distribution independently.
Let 퐴푖 ∈ {−1, 1}
퐾 represents the combination of assigned treatment to 푖th patient. Note that 푅푖,퐴푖 , the potential outcome when
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given 퐴푖 is defined by the following:
푅푖,퐴푖 =
∑
{푘∶퐴푖푘=1}
푇푘,푖 +푀푖 + 휎휖푖,퐴푖 , (19)
where 휖푖,퐴푖 follows standard normal distribution and is independent with any other random variables. It can be simply verified
that ∀훽푝,푘, 훽푛,푘, and 훾 , given any 퐴푖,
∑
{푘∶퐴푖푘=1}
푇푘,푖 +푀푖 ∈ [−12, 8]. Let 퐴
opt
푖
represents the selected combination of treatment,
given which the potential outcome is maximized. In our setting, 휎 is chosen to be 1.1. In fact, it can be observed that the Bayes
rule as defined in Equation 15 is the sign of the 푇푘,푖 for each 푘. In addition, based on Theorem 2 and 3, our proposed loss is
consistent with outcome weighted 0-1 loss in this setting.
In both DNN approaches, the activation function between hidden layer and output layer, or input layer and output layer is fixed
to be a simple centered monotone transformation. The activation function between input layer and hidden layer in DNN-1hdd
is chosen to be ReLU. 퐿1 penalty is applied to all the weights in both of DNN approaches.
To compare different methods, three scores are defined to quantify their performance. Two of the scores are based on
misclassification rate. Let 퐴̂푖 be the predicted combination of treatments. Usually, the misclassification rate is defined as
푀퐶푅 =
1
푛
푛∑
푖=1
1{퐴̂푖 ≠ 퐴opt푖 }. (20)
To account for the fact that 푃 (퐴
opt
푖
= 푎) is not the same, for all 푎 ⊂ {1,⋯ , 퐾}, the average of proportion of misclassification
rate is also proposed as following
퐴푀퐶푅 =
1
2퐾
∑
푎∈{−1,1}퐾
∑푛
푖=1
1{퐴̂푖 ≠ 푎, 퐴opt푖 = 푎}∑푛
푖=1
1{퐴
opt
푖
= 푎}
. (21)
To adjust MCR and AMCR based on the total number of combinations of treatments and make their performance comparable
with binary classifier for binary classification problem, adjusted MCR and AMCR is calculated by 1 − (1 − 푀퐶푅)1∕퐾 and
1 − (1 − 퐴푀퐶푅)1∕퐾 , respectively. Because in the framework of personalized medicine, the ultimate goal is not classification,
but better clinical outcome. Thus, it is primary to consider the average benefit which defines as following
퐴퐵 =
1
푛
푛∑
푖=1
푅푖,퐴̂푖
. (22)
For MCR (or adjusted MCR) and AMCR (or adjusted AMCR), lower is better. However, higher AB is preferred.
The simulation procedure works as follows. First, a training set and a validation set with the same sample size 푛푡푟푎푖푛퐾 are
generated separately, and a sequence of candidate tuning parameters are pre-specified, in this case, 0.1, 0.01, 0.001, 0.0001.
Then for each candidate tuning parameter, the Naive method, DNN-simple, and DNN-1hdd are trained on the training dataset
and tested on the validation set, where we compute the misclassification rate on the validation dataset for each method. The
tuning parameter gives the lowest misclassification rate on the validation set is selected, respectively for each method. At last,
we evaluate the three scores (MCR, AMCR, AB) under the selected tuning parameter on testing dataset which is independently
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TABLE 1 Comparison of naive method, DNN-simple, and DNN-1hdd by adjusted scores.
푛푡푟푎푖푛 Method adjusted MCR adjusted AMCR AB
200 Naive 0.4708(0.0026) 0.4652(0.0012) -1.5171(0.1004)
200 DNN-simple 0.2824(0.0022) 0.3555(0.0022) 0.5765(0.1172)
200 DNN-1hdd 0.2782(0.0028) 0.3709(0.0025) 0.6188(0.1200)
200 Bayes 0.0657(0.0001) 0.1108(0.0027) 3.1173(0.1143)
1000 Naive 0.3517(0.0024) 0.3729(0.0012) -0.0897(0.0948)
1000 DNN-simple 0.2125(0.0016) 0.3008(0.0028) 1.3609(0.1153)
1000 DNN-1hdd 0.2142(0.0015) 0.3240(0.0041) 1.3376(0.1145)
1000 Bayes 0.0657(0.0001) 0.1111(0.0027) 3.0871(0.1133)
4000 Naive 0.3083(0.0029) 0.3396(0.0018) 0.3502(0.0883)
4000 DNN-simple 0.1907(0.0014) 0.2902(0.0034) 1.7257(0.1166)
4000 DNN-1hdd 0.1806(0.0012) 0.2991(0.0050) 1.8435(0.1134)
4000 Bayes 0.0656(0.0000) 0.1140(0.0029) 3.1965(0.1127)
10000 Naive 0.2996(0.0035) 0.3305(0.0015) 0.4934(0.0766)
10000 DNN-simple 0.1846(0.0014) 0.2865(0.0033) 1.7272(0.1008)
10000 DNN-1hdd 0.1617(0.0012) 0.2889(0.0063) 1.9858(0.0986)
10000 Bayes 0.0657(0.0001) 0.1111(0.0027) 3.1272(0.0977)
generated with sample size 푛푡푒푠푡 = 10푛푡푟푎푖푛퐾 . The above procedure is repeated 100 times. The mean and standard error (SE) of
the scores are reported in Table 1 . Figure 4 shows a summary for adjusted scores and AB over 100 repeats.
Overall, DNN-1hdd performs the best in terms of MCR (or adjusted MCR) and AB. Note that Bayes method is infeasible in
practice, its superiority is because it takes advantage of the true model. The Bayes method serves as a reference to quantify the
best possible performance we could get in this problem. Although DNN-simple can only produce linear decision rules, which
don’t include the true decision rule, its performance is still competitive with DNN-1hdd because linear decision rule can explain
the true non-linear model to some extent, especially in small samples when the information is limited. The fact that DNN-1hdd
allows more flexibility also introduces additional variation. In general, DNN-1hdd performs slightly better than DNN-simple
with this bias and variance trade-off. In terms of AMCR (or adjusted AMCR), DNN-simple performs the best among all three
methods. FromTable 1 and Figure 4 , as the sample size increases, themisclassification decreases and average benefit increases
for all methods, which agrees with our consistency result proved in Theorem 2. However, the decreasing in MCR (or adjusted
MCR) becomes slower as sample size increases, because (1) the scores are lower bounded by Bayes rule; (2) the algorithm is
terminated after a certain times of iterations and takes the final update as the minimizer. In practice, one possible strategy is to
use a validation dataset to monitor the algorithm and pick the update with the best performance in validation dataset.
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FIGURE 4 Comparison of naive method, DNN-simple, and DNN-1hdd by adjusted MCR, AMCR, and AB.
6.2 Simulation with model mis-specification
In this section, we compare our two DNN approaches with a naive method when the condition in Theorem 2 is not satisfied.
The simulation procedure is the same as in Section 6.1 except for the way to generate 푅푖,퐴푖 . In this simulation, given 푇푘,푖 and
푀푖, the potential outcome is generated by
푅푖,퐴푖 =
∑
{푘∶퐴푖푘=1}
푇푘,푖 − 훾(
∑
{푘∶퐴푖푘=1}
푇푘,푖)
2 +푀푖 + 휎휖푖,퐴푖 , (23)
where 훾 = 0.1 and 휎 = 0.2. In this setting, it is easy to see that sup퐴 |훾(∑{푘∶퐴푖푘=1} 푇푘,푖)2| ≈ 10 and inf푘 |푇푘,푖| ≈ 2. Thus, the
condition in Theorem 2 is violated. The simulation procedure is the same as that described in Section 6.1.
The averages of Adjust MCR, AMCR, and AB over 100 repeats with their standard deviations are reported in Table 2
and Figure 5 , which show that our proposed methods DNN-1hdd and DNN-simple outperform Naive method with respect to
all three scores. Overall, DNN-1hdd has the best performance with respective to AB and adjusted MCR, while DNN-simple
performs the best when considering the adjusted AMCR. Although the Naive method is consistent, it performs very bad under
finite sample because of the high dimensionality of this problem. Our two DNN approaches still perform well when the small
interaction assumption is violated.
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FIGURE 5 Comparison of naive method, DNN-simple, and DNN-1hdd by adjusted MCR, AMCR, and AB with model mis-
specification.
TABLE 2 Comparison of naive method, DNN-simple, and DNN-1hdd by adjusted scores with model mis-specification.
푛푡푟푎푖푛 Method adjusted MCR adjusted AMCR AB
200 Naive 0.4863(0.0024) 0.4720(0.0017) -2.6427(0.0921)
200 DNN-simple 0.3048(0.0053) 0.3703(0.0029) -0.9197(0.0516)
200 DNN-1hdd 0.2994(0.0060) 0.3829(0.0028) -0.8746(0.0491)
200 Bayes 0.1157(0.0064) 0.1726(0.0027) 0.2124(0.0199)
1000 Naive 0.4074(0.0063) 0.4096(0.0022) -1.2951(0.0470)
1000 DNN-simple 0.2432(0.0063) 0.3244(0.0036) -0.4939(0.0308)
1000 DNN-1hdd 0.2433(0.0067) 0.3462(0.0043) -0.4885(0.0307)
1000 Bayes 0.1127(0.0065) 0.1732(0.0029) 0.2136(0.0164)
4000 Naive 0.3761(0.0070) 0.3898(0.0044) -1.1061(0.0424)
4000 DNN-simple 0.2323(0.0064) 0.3166(0.0040) -0.3592(0.0267)
4000 DNN-1hdd 0.2254(0.0070) 0.3275(0.0051) -0.3151(0.0247)
4000 Bayes 0.1199(0.0066) 0.1761(0.0028) 0.2293(0.0161)
10000 Naive 0.3890(0.0084) 0.4059(0.0020) -1.1827(0.0370)
10000 DNN-simple 0.2210(0.0053) 0.3102(0.0037) -0.3050(0.0279)
10000 DNN-1hdd 0.2016(0.0060) 0.3128(0.0060) -0.1966(0.0247)
10000 Bayes 0.1146(0.0054) 0.1761(0.0027) 0.2354(0.0172)
7 REAL DATA ANALYSIS
In this section, we apply our method to an electronic health record (EHR) data for type 2 diabetes patients from Clinical Prac-
tice Research Datalink (CPRD). 1139 patients are included in the dataset. For each patient, 21 covariates are collected before
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treatment assignment, which include demographical variables such as gender, BMI, HDL, and LDL, and also indicator of com-
plications such as stroke and hypertension. The primary endpoint is change in A1c. Because A1c typically drops after applying
the treatments, the primary endpoint is always negative and smaller is preferable. Thus, the proposed method can be easily
implemented by considering negative change in A1c as patient outcome.
In this dataset, 4 treatments are considered for each patient, DDP4, sulfonylurea (SU), metformin (MET), and TZD. These
4 treatments function via four different biological processes. DDP4 increases incretin levels, which inhibits glucagon release.
SU increases insulin release from 훽-cell in pancreas. MET decreases glucose production by the liver and increase the insulin
sensitivity of body tissue. TZDmakes cells more dependent on oxidation of carbohydrates. These 4 treatments target on different
cells or functional organs, so it is reasonable to assume little treatment interaction among them and additive treatment effects.
In this real dataset, 퐾 = 4, resulting in 16 possible combinations of treatments. Because the original average benefit score
can not be directly calculated in real settings, the naive method, DNN-1hdd, and DNN-simple are evaluated under a weighted
version of average benefit defined as follows,
푇 =
∑푛
푖=1
푤푖푅푖∑푛
푖=1
푤푖
,
where 푤푖 =
퐼{퐴̂푖=푎푖}
푃 (퐴푖=푎푖|푋푖) , 푎푖 is the observed treatment assignment, 푅푖 is the negative change in A1c, 퐴̂푖 is the predicted treatment
assignment for the 푖th patient. Intuitively, 푇 is the weighted average of change in A1c over all the patients with the same treatment
assignment as our predicted treatment assignment, which estimates the change in A1c if the fitted treatment assignment is
adopted. If our proposed methods can recover the underlying optimal decision rule to some extent, their 푇 are expected to be
lower than that of the naive method, indicating higher efficacy of our treatment recommendations. In addition, the number of
patients푁 satisfying 푎푖 = 퐴̂푖 is also reported.
Multiple imputation is adopted to deal with missing data. Because of the randomness of the multiple imputation, 5 different
imputed datasets are analyzed following the same procedure, and then the scores from these 5 imputed data are summarized by
average.
For each imputed dataset, we do the following. Firstly, the whole dataset is randomly split into two datasets, training set and
testing set. Training set contains 912 patients, and testing dataset contains 227 patients. All three methods are fitted on training
set respectively, and the score for each of the method is calculated based on the testing set. This procedure is repeated 100 times,
each time the score is recorded. After summarizing these scores across 5 imputed datasets, the mean of 푇 ,푁 and their standard
errors (SEs) are reported in Table 3 , and all results over 100 repeats are shown by boxplots in Figure 6 .
It can be observed that both DNN-simple and DNN-1hdd have lower 푇 compared with naive method. Moreover, both DNN
methods show significant effect on A1c while naive method does not. Comparing between two DNN methods, DNN-1hdd
performs slightly better thanDNN-simple in terms of 푇 . In addition,푁 , which is the size of the subgroupwith the same treatment
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TABLE 3 Comparison of Naive method, DNN-simple, and DNN-1hdd by scores in real data example. 푇 is the weighted
average of change in A1c over all the patients with the same treatment assignment as the method suggests.푁 is the number of
the patients whose treatment assignment coincide with the predicted.
Method 푇 푁
Naive -1.534(0.078) 4.410(0.107)
DNN-simple -2.605(0.058) 23.058(0.371)
DNN-1hdd -2.695(0.057) 25.790(0.394)
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FIGURE 6 Boxplots of scores for Naive method, DNN-simple, and DNN-1hdd over 100 repeats .
assignment as predicted for our proposed methods, is much larger than that for naive method. Overall, our proposed methods
have better performance than naive method, and DNN-1hdd is slightly better than DNN-simple.
8 CONCLUSIONS AND DISCUSSIONS
In this paper, an outcome weighted deep learning framework is proposed to estimate optimal combination therapies. Both simu-
lation and real data analysis provide solid evidence on the power of our proposedmethod. Essentially, the proposed loss, outcome
weighted Hamming loss, can be applied to any occasion, even when deep learning is not a desired classifier. For example, linear
classifiers can be used in the case when efficiency and convexity is very important. Although other nonlinear classifiers can also
be adopted, when adopting these methods, advantages of deep learning such as sharing subspace may disappear unless inducing
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certain techniques such as dimension reduction. Deep learning framework can also be applied under other losses. For example,
partial ranking loss proposed in [27] can also be combined with deep learning approach. However, for ranking based loss func-
tion, one of the significant drawback is the lack of ‘zero’ point to distinguish between good treatments and bad treatments. In
other word, ranking based loss function can only provide a rank of treatments instead of recommending treatment. In this paper,
the advantages of adopting deep learning approach and the loss function has been articulated . Our method enjoys all of these
advantages.
Furthermore, the proposed method is critical for future research. It can be extended in multiple directions. The first possible
extension focuses on loss functions. In previous sections, it is easy to observe that Hamming loss provides an approximation to
the original 0-1 loss. As we have shown, this approximation is done by overlooking strong interactions among treatments. While
original 0-1 loss is very flexible so that it is generally consistent, the huge number of parameters to be estimated may undermine
the efficiency and lead to huge computation costs. Thus, a natural extension of our method is to design a family of loss functions
such that our method can be adaptive to certain amount of interactions among treatments. For example, Hamming loss is the
proportion of mis-classified labels, and can be rewritten into the following
1 −
1
퐾
퐾∑
푘=1
1
{
퐴푘 = 퐷푘
}
.
0-1 loss can also be rewritten into the following
1 −
퐾∏
푘=1
1
{
퐴푘 = 퐷푘
}
.
Naturally, a family of loss functions can be defined as
1 −
1(
휏
퐾
) ∑
{푘1⋯,푘휏}⊂{1,⋯,퐾}
휏∏
푞=1
1
{
퐴푘푞 = 퐷푘푞
}
,
where 휏 is a parameter. We call it 휏th order Hamming loss. When 휏 = 1, it is the same as Hamming loss, which has the most
strict conditions on treatment interactions in order to guarantee its fisher consistency. When 휏 = 퐾 , it is actually 0-1 loss, which
has the fewest conditions on treatment interactions in order to guarantee its fisher consistency. With the increasing of 휏, the loss
function can accommodate more and more interactions, but may lead to more and more parameters to be estimated. Thus, the
existence of 휏 allows us to choose loss function adaptively to the data.
The second possible extension focuses on the dynamic assignment of multiple treatments. Combination therapies considered
in this paper do not involve treatment transition problem. For the real data analysis and simulation, all the treatment are assumed
to be applied to the patient at the same time. However, this is not always true in real life. Patients typically change from one
treatment to another. Thus, instead of deciding a static treatment assignment, a dynamic treatment assignment with transition
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scheduling is a more realistic and reasonable solution to precision medicine. During this process, multiple outcomes may also
be involved in the analysis. The process of single outcome over time may also play an important role in this extension.
The third extension focuses on how to combine our proposed technique with methods in [2] and [3] such that we can directly
estimate the contrasts of treatment effects. In this case, it is critical to model the potential outcomes and propensity scores in an
efficient way, especially for combination therapies. In general, our work in this paper is the keystone to all these potentials.
One of the limitations in our proposed method is that our method may fail under large interactions between treatments. When
the interactions between treatments share the same direction of treatment recommendations, our method still holds, even the
condition in 2 fails. For example, in the simulation with model mis-specification, if 훾 ≤ 0, it can be shown that our method is
still consistent but the condition in 2 fails. When the interactions between treatments are large and have the opposite direction
of treatment recommendations, for example, it is extremely harmful to take two good medications simultaneously. Each com-
bination therapy should be considered as a totally new treatment whose effect is irrelevant to the treatment effects when taking
medications separately. In this case, treatment recommendation should be considered as a multi-class classification problem
rather than a multi-label classification problem, and no information can be borrowed to improve efficiency.
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APPENDIX A: PROOF OF THEOREMS
Proof of Theorem 1. Let us compute the minimizer for the proposed Hamming loss.
퐻 (퐷) = 퐸
[
푅
휋퐴
1
퐾
퐾∑
푘=1
퐼{퐴푘 ≠ 퐷푘(푋)}
]
= 퐸
{
1
퐾
퐾∑
푘=1
[ ∑
{푎∶푎푘=1}
퐸[푅|퐴 = 푎,푋]퐼{1 ≠ 퐷푘(푋)} + ∑
{푎∶푎푘=−1}
퐸[푅|퐴 = 푎,푋]퐼{−1 ≠ 퐷푘(푋)}]} .
It is easy to see that the minimizer of the proposed Hamming loss, 푓 = (푓1,⋯ , 푓퐾 ) ∈ {−1, 1}
퐾 , can be written as 푓푘 =
sign
{∑
{푎∶푎푘=1}
퐸[푅|퐴 = 푎,푋] −∑{푎∶푎푘=−1} 퐸[푅|퐴 = 푎,푋]} , ∀푘 ∈ {1,⋯ , 퐾}. Thus, the conclusion follows given the
condition that 퐷∗
푘
(푋) = sign
{∑
{푎∶푎푘=1}
퐸[푅|퐴 = 푎,푋] −∑{푎∶푎푘=−1} 퐸[푅|퐴 = 푎,푋]}.
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Proof of Theorem 2. We claim that the퐷∗(푋) in this case is the combination of all the treatments with 푇푒푘 (푋) > 0. For any
other decision rule 퐷(푋) ≠ 퐷∗(푋),
퐸[푅|퐴 = 퐷∗(푋), 푋] − 퐸[푅|퐴 = 퐷(푋), 푋]
=
∑
{푘∶푇푒푘
(푋)>0}
푇푒푘(푋) + 푟퐷∗(푋) −
∑
{푘∶퐷푘(푋)=1}
푇푒푘 (푋) − 푟퐷(푋)
≥ inf
푘
|푇푒푘(푋)| − 2 sup
푎
|푟푎(푋)|
>0.
Thus, our claim is true, 퐷∗
푘
(푋) = sign(푇푒푘). Now, let us compute the following.∑
{푎∶푎푘=1}
퐸[푅|퐴 = 푎,푋] − ∑
{푎∶푎푘=−1}
퐸[푅|퐴 = 푎,푋]
=
∑
{푎∶푎푘=1}
{ ∑
{푘′∶푎푘′=1}
푇푒푘′ (푋) + 푟푎(푋)
}
−
∑
{푎∶푎푘=−1}
{ ∑
{푘′∶푎푘′=1}
푇푒′
푘
(푋) + 푟푎(푋)
}
≥ ∑
{푎∶푎푘=1}
{ ∑
{푘′∶푎푘′=1,푘≠푘′}
푇푒푘′ (푋)
}
−
∑
{푎∶푎푘=−1}
{ ∑
{푘′∶푎푘′=1,푘≠푘′}
푇푒푘′ (푋)
}
+ 2퐾−1푇푒푘 (푋) − 2
퐾 sup
푎
|푟푎(푋)|
=2퐾−1[푇푒푘 (푋) − 2 sup
푎
|푟푎(푋)|]
Thus, sign
{∑
{푎∶푎푘=1}
퐸[푅|퐴 = 푎,푋] −∑{푎∶푎푘=−1} 퐸[푅|퐴 = 푎,푋]} = sign(푇푒푘). The conclusion follows.
Proof of Theorem 3. Let us compute
Φ퐻(퐷̃) = 퐸
[
푅
휋퐴
1
퐾
퐾∑
푘=1
휙(퐴푘퐷̃푘(푋))
]
= 퐸
{
1
퐾
퐾∑
푘=1
[ ∑
{푎∶푎푘=1}
퐸[푅|퐴 = 푎,푋]휙(퐷̃푘(푋)) + ∑
{푎∶푎푘=−1}
퐸[푅|퐴 = 푎,푋]휙(−퐷̃푘(푋))]} .
Let 휂 =
∑
{푎∶푎푘=1}
퐸[푅|퐴=푎,푋]∑
{푎∶푎푘=1}
퐸[푅|퐴=푎,푋]+∑{푎∶푎푘=−1} 퐸[푅|퐴=푎,푋] , by [28], the conclusion follows.
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